Physician profile
Chang Min Yim
NPI 1417398405
$49,426.37
in general payments reported to CMS, 2019-2025
11 companies · $15K in 2025
The $15K reported for 2025 was more than what 97% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2021: $12K · 2022: $13K · 2023: $3,551 · 2024: $5,574 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $11K · Honoraria: $9,100 · Food and Beverage: $2,014 · Travel and Lodging: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $11,450.00 |
| Honoraria | $9,100.00 |
| Food and Beverage | $2,014.39 |
| Travel and Lodging | $1,397.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $42,506.43 | 2021-2025 | Ips, Cutting Guide, W/Planning, Transform, Lp, Qty: 001 Ea, Ips, Cutting Guide, Transform, Extra, Large, Lp, Qty: 001 Ea, Ips, Supplemental Model, Transform, Half, Lp, Qty: 001 Ea |
| Hiossen, INC. | $3,600.00 | 2024 | |
| Biotissue Holdings INC. | $1,643.83 | 2024 | |
| Nexus Cmf, LLC | $509.50 | 2023 | Mccain Arthroscopy System |
| Zimmer Biomet Holdings, INC. | $490.56 | 2019 | |
| Depuy Synthes Sales INC. | $212.04 | 2024 | Trumatch |
| Kerecis Limited | $191.62 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimvie INC. | $168.57 | 2022-2025 | |
| Immersivetouch, INC. | $50.64 | 2025 | Immersivetouch |
| Stryker Corporation | $38.54 | 2025 | Na |
| Cook Medical LLC | $14.64 | 2023 | Biodesign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chang Min Yim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.